4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0001209191-21-009413
Director acquired 2,407,328 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Peyer James Director | 2021-02-08 | Conversion | +2,407,328 | 4,690,153 | I: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Peyer James Director | 2021-02-08 | Conversion · Series AA Preferred Convertible Stock | −110,729,827 | 0 | I: show line 2 in the form | ||
| Peyer James Director | 2021-02-08 | Conversion · Series BB Preferred Convertible Stock | −4,821,996 | 0 | I: show line 3 in the form |
Loading xslF345X03/doc4.xml…